Alkira Bio is a Melbourne-based startup that is focused on the research and development of therapies for neurodegenerative diseases. Founded in 2020, Alkira Bio aims to address the unmet needs in this area by advancing the understanding of the molecular mechanisms that cause these diseases. Their efforts are primarily concentrated on creating therapies for Alzheimer's and other related diseases.

The company is actively engaged in developing small molecule drugs that have the potential to slow the progression of neurodegenerative diseases. Alkira Bio collaborates with various research institutions and pharmaceutical companies, leveraging their combined knowledge and resources to accelerate drug discovery and development. This collaborative approach, along with their focus on rigorous scientific research, is helping Alkira Bio make strides in the fight against neurodegenerative diseases.

Connect